Thymoquinone: A promising anti-cancer drug from natural sources

There has been growing interest in naturally occurring compounds with anti-cancer potential. Black seed is one of the most extensively studied plants. This annual herb grows in countries bordering the Mediterranean Sea and India. Thymoquinone (TQ) is the bioactive constituent of the volatile oil of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The international journal of biochemistry & cell biology 2006, Vol.38 (8), p.1249-1253
Hauptverfasser: Gali-Muhtasib, Hala, Roessner, Albert, Schneider-Stock, Regine
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1253
container_issue 8
container_start_page 1249
container_title The international journal of biochemistry & cell biology
container_volume 38
creator Gali-Muhtasib, Hala
Roessner, Albert
Schneider-Stock, Regine
description There has been growing interest in naturally occurring compounds with anti-cancer potential. Black seed is one of the most extensively studied plants. This annual herb grows in countries bordering the Mediterranean Sea and India. Thymoquinone (TQ) is the bioactive constituent of the volatile oil of black seed. It has been shown to exert anti-neoplastic and anti-inflammatory effects. The molecular pathways of TQ action are not clear. Nevertheless, TQ is known to induce apoptosis by p53-dependent and p53-independent pathways in cancer cell lines. Growth inhibition is associated with induction of cell cycle arrest. TQ also acts on the immune system by modulating the levels of inflammatory mediators. To date, the chemotherapeutic potential of TQ in the clinic has not been tested, but numerous studies have shown its promising anti-cancer effects in animal models. The combination of TQ with clinically used anti-cancer drugs has led to improvements in their therapeutic index and prevents non-tumor tissues from sustaining chemotherapy-induced damage.
doi_str_mv 10.1016/j.biocel.2005.10.009
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67942269</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1357272505003614</els_id><sourcerecordid>67942269</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-4d606cc9492fc5991bf4631653967345b334b0a22391975a3c1d02532beb21993</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRb0A0VL4A4SyYpfgd2QWoKoqD6kSm7K2HMcprpK4tWOk_j2OUokdq5Fm7szcewC4Q7BAEPHHfVFZp01bYAhZahUQigswR4SVOS4xm4HrEPYQQsQwuQIzxAmiiPA5eNl-nzp3jLZ3vXnKltnBu84G2-8y1Q8216rXxme1j7usSaOsV0P0qs2Ci16bcAMuG9UGc3uuC_D1ut6u3vPN59vHarnJNcV8yGnNIddaUIEbzYRAVUOTB86I4CWhrCKEVlBhTAQSJVNEoxpiRnBlKoyEIAvwMN1N_o7RhEEmlylxq3rjYpC8FBRjPgrpJNTeheBNIw_edsqfJIJyhCX3coIlR1hjN8FKa_fn-7HqTP23dCaVBM-TwKSUP9Z4GbQ1CU5tvdGDrJ39_8Mviit9BQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67942269</pqid></control><display><type>article</type><title>Thymoquinone: A promising anti-cancer drug from natural sources</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Gali-Muhtasib, Hala ; Roessner, Albert ; Schneider-Stock, Regine</creator><creatorcontrib>Gali-Muhtasib, Hala ; Roessner, Albert ; Schneider-Stock, Regine</creatorcontrib><description>There has been growing interest in naturally occurring compounds with anti-cancer potential. Black seed is one of the most extensively studied plants. This annual herb grows in countries bordering the Mediterranean Sea and India. Thymoquinone (TQ) is the bioactive constituent of the volatile oil of black seed. It has been shown to exert anti-neoplastic and anti-inflammatory effects. The molecular pathways of TQ action are not clear. Nevertheless, TQ is known to induce apoptosis by p53-dependent and p53-independent pathways in cancer cell lines. Growth inhibition is associated with induction of cell cycle arrest. TQ also acts on the immune system by modulating the levels of inflammatory mediators. To date, the chemotherapeutic potential of TQ in the clinic has not been tested, but numerous studies have shown its promising anti-cancer effects in animal models. The combination of TQ with clinically used anti-cancer drugs has led to improvements in their therapeutic index and prevents non-tumor tissues from sustaining chemotherapy-induced damage.</description><identifier>ISSN: 1357-2725</identifier><identifier>DOI: 10.1016/j.biocel.2005.10.009</identifier><identifier>PMID: 16314136</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Animals ; Anti-cancer ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Antineoplastic Agents - therapeutic use ; Apoptosis ; Apoptosis - drug effects ; Benzoquinones - chemistry ; Benzoquinones - pharmacology ; Benzoquinones - therapeutic use ; Cell cycle ; Cell Cycle - drug effects ; Humans ; Inflammation ; Molecular Structure ; Neoplasms - drug therapy ; Neoplasms - metabolism ; Plants, Medicinal - chemistry ; Thymoquinone ; Tumor Suppressor Protein p53 - metabolism</subject><ispartof>The international journal of biochemistry &amp; cell biology, 2006, Vol.38 (8), p.1249-1253</ispartof><rights>2005 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-4d606cc9492fc5991bf4631653967345b334b0a22391975a3c1d02532beb21993</citedby><cites>FETCH-LOGICAL-c426t-4d606cc9492fc5991bf4631653967345b334b0a22391975a3c1d02532beb21993</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.biocel.2005.10.009$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,4022,27921,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16314136$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gali-Muhtasib, Hala</creatorcontrib><creatorcontrib>Roessner, Albert</creatorcontrib><creatorcontrib>Schneider-Stock, Regine</creatorcontrib><title>Thymoquinone: A promising anti-cancer drug from natural sources</title><title>The international journal of biochemistry &amp; cell biology</title><addtitle>Int J Biochem Cell Biol</addtitle><description>There has been growing interest in naturally occurring compounds with anti-cancer potential. Black seed is one of the most extensively studied plants. This annual herb grows in countries bordering the Mediterranean Sea and India. Thymoquinone (TQ) is the bioactive constituent of the volatile oil of black seed. It has been shown to exert anti-neoplastic and anti-inflammatory effects. The molecular pathways of TQ action are not clear. Nevertheless, TQ is known to induce apoptosis by p53-dependent and p53-independent pathways in cancer cell lines. Growth inhibition is associated with induction of cell cycle arrest. TQ also acts on the immune system by modulating the levels of inflammatory mediators. To date, the chemotherapeutic potential of TQ in the clinic has not been tested, but numerous studies have shown its promising anti-cancer effects in animal models. The combination of TQ with clinically used anti-cancer drugs has led to improvements in their therapeutic index and prevents non-tumor tissues from sustaining chemotherapy-induced damage.</description><subject>Animals</subject><subject>Anti-cancer</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Benzoquinones - chemistry</subject><subject>Benzoquinones - pharmacology</subject><subject>Benzoquinones - therapeutic use</subject><subject>Cell cycle</subject><subject>Cell Cycle - drug effects</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Molecular Structure</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - metabolism</subject><subject>Plants, Medicinal - chemistry</subject><subject>Thymoquinone</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><issn>1357-2725</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtOwzAQRb0A0VL4A4SyYpfgd2QWoKoqD6kSm7K2HMcprpK4tWOk_j2OUokdq5Fm7szcewC4Q7BAEPHHfVFZp01bYAhZahUQigswR4SVOS4xm4HrEPYQQsQwuQIzxAmiiPA5eNl-nzp3jLZ3vXnKltnBu84G2-8y1Q8216rXxme1j7usSaOsV0P0qs2Ci16bcAMuG9UGc3uuC_D1ut6u3vPN59vHarnJNcV8yGnNIddaUIEbzYRAVUOTB86I4CWhrCKEVlBhTAQSJVNEoxpiRnBlKoyEIAvwMN1N_o7RhEEmlylxq3rjYpC8FBRjPgrpJNTeheBNIw_edsqfJIJyhCX3coIlR1hjN8FKa_fn-7HqTP23dCaVBM-TwKSUP9Z4GbQ1CU5tvdGDrJ39_8Mviit9BQ</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>Gali-Muhtasib, Hala</creator><creator>Roessner, Albert</creator><creator>Schneider-Stock, Regine</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2006</creationdate><title>Thymoquinone: A promising anti-cancer drug from natural sources</title><author>Gali-Muhtasib, Hala ; Roessner, Albert ; Schneider-Stock, Regine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-4d606cc9492fc5991bf4631653967345b334b0a22391975a3c1d02532beb21993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Anti-cancer</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Benzoquinones - chemistry</topic><topic>Benzoquinones - pharmacology</topic><topic>Benzoquinones - therapeutic use</topic><topic>Cell cycle</topic><topic>Cell Cycle - drug effects</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Molecular Structure</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - metabolism</topic><topic>Plants, Medicinal - chemistry</topic><topic>Thymoquinone</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gali-Muhtasib, Hala</creatorcontrib><creatorcontrib>Roessner, Albert</creatorcontrib><creatorcontrib>Schneider-Stock, Regine</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The international journal of biochemistry &amp; cell biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gali-Muhtasib, Hala</au><au>Roessner, Albert</au><au>Schneider-Stock, Regine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thymoquinone: A promising anti-cancer drug from natural sources</atitle><jtitle>The international journal of biochemistry &amp; cell biology</jtitle><addtitle>Int J Biochem Cell Biol</addtitle><date>2006</date><risdate>2006</risdate><volume>38</volume><issue>8</issue><spage>1249</spage><epage>1253</epage><pages>1249-1253</pages><issn>1357-2725</issn><abstract>There has been growing interest in naturally occurring compounds with anti-cancer potential. Black seed is one of the most extensively studied plants. This annual herb grows in countries bordering the Mediterranean Sea and India. Thymoquinone (TQ) is the bioactive constituent of the volatile oil of black seed. It has been shown to exert anti-neoplastic and anti-inflammatory effects. The molecular pathways of TQ action are not clear. Nevertheless, TQ is known to induce apoptosis by p53-dependent and p53-independent pathways in cancer cell lines. Growth inhibition is associated with induction of cell cycle arrest. TQ also acts on the immune system by modulating the levels of inflammatory mediators. To date, the chemotherapeutic potential of TQ in the clinic has not been tested, but numerous studies have shown its promising anti-cancer effects in animal models. The combination of TQ with clinically used anti-cancer drugs has led to improvements in their therapeutic index and prevents non-tumor tissues from sustaining chemotherapy-induced damage.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>16314136</pmid><doi>10.1016/j.biocel.2005.10.009</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1357-2725
ispartof The international journal of biochemistry & cell biology, 2006, Vol.38 (8), p.1249-1253
issn 1357-2725
language eng
recordid cdi_proquest_miscellaneous_67942269
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Animals
Anti-cancer
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Antineoplastic Agents - therapeutic use
Apoptosis
Apoptosis - drug effects
Benzoquinones - chemistry
Benzoquinones - pharmacology
Benzoquinones - therapeutic use
Cell cycle
Cell Cycle - drug effects
Humans
Inflammation
Molecular Structure
Neoplasms - drug therapy
Neoplasms - metabolism
Plants, Medicinal - chemistry
Thymoquinone
Tumor Suppressor Protein p53 - metabolism
title Thymoquinone: A promising anti-cancer drug from natural sources
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T23%3A41%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thymoquinone:%20A%20promising%20anti-cancer%20drug%20from%20natural%20sources&rft.jtitle=The%20international%20journal%20of%20biochemistry%20&%20cell%20biology&rft.au=Gali-Muhtasib,%20Hala&rft.date=2006&rft.volume=38&rft.issue=8&rft.spage=1249&rft.epage=1253&rft.pages=1249-1253&rft.issn=1357-2725&rft_id=info:doi/10.1016/j.biocel.2005.10.009&rft_dat=%3Cproquest_cross%3E67942269%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67942269&rft_id=info:pmid/16314136&rft_els_id=S1357272505003614&rfr_iscdi=true